[HTML][HTML] Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms

A Stirban, T Gawlowski, M Roden - Molecular metabolism, 2014 - Elsevier
The enhanced generation and accumulation of advanced glycation endproducts (AGEs)
have been linked to increased risk for macrovascular and microvascular complications …

The role of advanced glycation end products in progression and complications of diabetes

SY Goh, ME Cooper - The Journal of Clinical Endocrinology & …, 2008 - academic.oup.com
Context: Diabetic complications appear to be multifactorial in origin, but in particular, the
biochemical process of advanced glycation, which is accelerated in diabetes as a result of …

Dietary advanced glycation end products and aging

C Luevano-Contreras, K Chapman-Novakofski - Nutrients, 2010 - mdpi.com
Advanced glycation end products (AGEs) are a heterogeneous, complex group of
compounds that are formed when reducing sugar reacts in a non-enzymatic way with amino …

How hyperglycemia promotes atherosclerosis: molecular mechanisms

D Aronson, EJ Rayfield - Cardiovascular diabetology, 2002 - Springer
Both type I and type II diabetes are powerful and independent risk factors for coronary artery
disease (CAD), stroke, and peripheral arterial disease. Atherosclerosis accounts for virtually …

[PDF][PDF] Diabetes and advanced glycoxidation end products

AG Huebschmann, JG Regensteiner, H Vlassara… - Diabetes …, 2006 - academia.edu
The morbidity caused by diabetes has traditionally been classified into macro-and
microvascular complications. Although macrovascular complications have received greater …

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

BK Kilhovd, TJ Berg, KI Birkeland, P Thorsby… - Diabetes …, 1999 - Am Diabetes Assoc
OBJECTIVE: To investigate whether serum levels of advanced glycation end products
(AGEs) and the glycoxidation product Nepsilon-(carboxymethyl) lysine (CML) are increased …

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

J Nourooz-Zadeh, A Rahimi, J Tajaddini-Sarmadi… - Diabetologia, 1997 - Springer
Diabetes mellitus may be associated with increased lipid peroxidation which may contribute
to long-term tissue damage. To test this hypothesis, we measured hydroperoxides (ROOHs) …

Diabetes and cardiovascular disease: inter-relation of risk factors and treatment

A Sharma, S Mittal, R Aggarwal… - Future Journal of …, 2020 - Springer
Background The diabetes mellitus prevalence is still advancing and increasingly becoming
one of the globally most severe and expensive chronic illnesses. The strong correlation …

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential …

NL Reynaert, P Gopal, EPA Rutten… - The international journal …, 2016 - Elsevier
Age-related, non-communicable chronic inflammatory diseases represent the major 21st
century health problem. Especially in Western countries, the prevalence of non …

Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment

H Gylling, TA Miettinen - Diabetologia, 1994 - Springer
Cholesterol absorption and metabolism and LDL and HDL kinetics were investigated in 11
hypercholesterolaemic non-insulin-dependent diabetic men off and on a hypolipidaemic …